Your browser does not fully support modern features. Please upgrade for a smoother experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Adult Abdominal Tuberculosis Diagnosis
Tuberculosis is a common systemic infection with the bacteria Mycobacterium tuberculosis, which is primarily found in the lungs and causes caseous inflammation in lung tissue and other organs. Tuberculosis is an infectious disease that spreads via the air. Tuberculosis is an endemic disease in developing countries, due to the wide spread of acquired immunodeficiency syndrome (AIDS), it might represent a problem in developed countries, as well. Only around one-fifth of patients diagnosed with abdominal TB have pulmonary disease. 
  • 1.2K
  • 29 Mar 2022
Topic Review
Skin and Soft Tissue Infections
Skin and soft tissue infections are one of the most frequent types of infection, typically requiring medical intervention and contribute to morbidity and mortality in both primary care and hospitalised patients. Current antiseptics used in prevention are mainly formulated as traditional, simple dosage forms such as solutions and semi-solids. In recent years, there have been studies reporting the potential for nanotechnology ito improve the delivery of antiseptics.
  • 1.2K
  • 24 May 2021
Topic Review
Thymus Gland
The thymus gland is the chief lymphoid organ that regulates the functions of the immune and endocrine systems by controlling the levels of hormones and cytokines. The thymus gland protects against various internal and external stresses through immunoregulatory properties, nerve systems, and endocrine pathways. The thymus gland controls cell proliferation, apoptosis, hormones, and neuropeptides, as well as regulating intrathymic T cell differentiation and production of a repertoire of the T cell.
  • 1.2K
  • 26 Oct 2021
Topic Review
Subacute Thyroiditis and the COVID-19
Subacute thyroiditis (SAT), also known as De Quervain or granulomatous thyroiditis, is caused by a viral infection, especially (but not exclusively) of the upper respiratory tract or by post-viral inflammation. Since 2020, the entity has been listed in association with the coronavirus disease 2019 (COVID-19) infection, and since 2021 it has been related to the vaccine against the virus.
  • 1.2K
  • 02 Jun 2022
Topic Review
Pneumococcal Vaccination during COVID-19
The emergence of new viral infections has increased over the decades. The novel virus is one such pathogen liable for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, popularly known as coronavirus disease 2019 (COVID-19). Most fatalities during the past century’s influenza pandemics have cooperated with bacterial co/secondary infections. Unfortunately, many reports have claimed that bacterial co-infection is also predominant in COVID-19 patients (COVID-19 associated co/secondary infection prevalence is up to 45.0%). In the COVID-19 pandemic, Streptococcus pneumoniae is the most common coinfecting pathogen. Half of the COVID-19 mortality cases showed co-infection, and pneumonia-related COVID-19 mortality in patients >65 years was 23%. The weakening of immune function caused by COVID-19 remains a high-risk factor for pneumococcal disease. Pneumococcal disease and COVID-19 also have similar risk factors. For example, underlying medical conditions on COVID-19 and pneumococcal diseases increase the risk for severe illness at any age; COVID-19 is now considered a primary risk factor for pneumococcal pneumonia and invasive pneumococcal disease. Thus, pneumococcal vaccination during the COVID-19 pandemic has become more critical than ever. 
  • 1.2K
  • 06 Jan 2022
Topic Review
Host-Directed Therapies (HDTs) for the Treatment of COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak resulted in hundreds of millions of coronavirus cases, as well as millions of deaths worldwide. Coronavirus Disease 2019 (COVID-19), the disease resulting from exposure to this pathogen, is characterized, among other features, by a pulmonary pathology, which can progress to “cytokine storm”, acute respiratory distress syndrome (ARDS), respiratory failure and death. An important strategy for protecting against the SARS-CoV-2 infection may rely on clinically evaluated pharmacological-based countermeasures, including host-directed therapies (HDTs), which modulate the endogenic response against the virus.
  • 1.2K
  • 13 Jul 2023
Topic Review
Epidemiology of Elizabethkingia spp. Infections in Southeast Asia
Elizabethkingia spp. is a ubiquitous pathogenic bacterium that has been identified as the causal agent for a variety of conditions such as meningitis, pneumonia, necrotizing fasciitis, endophthalmitis, and sepsis and is emerging as a global threat including in Southeast Asia. Elizabethkingia infections tend to be associated with high mortality rates (18.2–41%) and are mostly observed in neonates and immunocompromised patients. Difficulties in precisely identifying Elizabethkingia at the species level by traditional methods have hampered the understanding of this genus in human infections. In Southeast Asian countries, hospital outbreaks have usually been ascribed to E. meningoseptica, whereas in Singapore, E. anophelis was reported as the main Elizabethkingia spp. associated with hospital settings. Misidentification of Elizabethkingia spp. could, however, underestimate the number of cases attributed to the bacterium, as precise identification requires tools such as MALDI-TOF MS, and particularly whole-genome sequencing, which are not available in most hospital laboratories. Elizabethkingia spp. has an unusual antibiotic resistance pattern for a Gram-negative bacterium with a limited number of horizontal gene transfers, which suggests an intrinsic origin for its multidrug resistance.
  • 1.1K
  • 22 Jul 2022
Topic Review
Human Herpesviruses
Human herpesviruses (HHVs): herpes simplex virus (HSV) types 1 (HSV-1) and 2 (HSV-2), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), HHV-6, HHV-7, and HHV-8, are known to be part of a family of DNA viruses that cause several diseases in humans. In clinical practice of inflammatory bowel disease (IBD), the complication of CMV enterocolitis, which is caused by CMV reactivation under disruption of intestinal barrier function, inflammation, or strong immunosuppressive therapy, is well known to affect the prognosis of disease. However, the relationship between other HHVs and IBD remains unclear.
  • 1.1K
  • 27 Sep 2021
Topic Review
Blood Culture-Negative Infective Endocarditis by Mycoplasma hominis
Mycoplasma hominis is a habitual colonizing microorganism of the lower genital tract but can exceptionally be the causal agent of blood culture-negative infective endocarditis (IE). 
  • 1.1K
  • 21 Jul 2022
Topic Review
Major Pharmacological Actions of Quercetin
Quercetin (3,3′,4′,5,7-pentahydroxy-2-phenylchromen-4-one), the major representative of the flavonoid subclass of flavonols, is derived from the Latin word “Quercetum,” meaning “Oak Forest”. It can be found in a variety of foods, including fruits and vegetables, and has been reported to be effective against a variety of viruses. 
  • 1.1K
  • 02 Feb 2023
Topic Review
Dendrimers for Infectious Diseases
Functionalized and modified dendrimer platforms are capable of precise imaging and efficient treatment of tumors, providing solutions for combined monitoring and early treatment of cancers.
  • 1.1K
  • 05 Jul 2021
Topic Review
Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs
Highly active anti-retroviral therapy (HAART) is prescribed for HIV infection and, to a certain extent, limits the infection’s spread. Nanopharmaceuticals offer excellent treatment options for HIV infections by improving the drug potency/efficacy, lowering the dose-related toxicities, and providing active targeting options to the remote HIV reservoirs, leading to the near-total eradication of the virus. Nanopharmaceuticals offer advantages over conventional drug delivery, such as an encapsulation of the drug in nanocarriers, despite its physiochemical properties, providing long-acting treatment options and reducing the dosing because of selective targeting and improvements to the bioavailability of the hydrophobic drugs and adherence of the patients. 
  • 1.1K
  • 15 Sep 2022
Topic Review
Pathophysiology and Epidemiology of COVID-19
The WHO declared coronavirus disease 2019 (COVID-19) a pandemic in March 2020, which was caused by novel coronavirus severe acute respiratory coronavirus 2 (SARS-CoV-2). SARS-CoV-2 made its first entry into the world in November 2019, and the first case was detected in Wuhan, China. Mutations in the SARS-CoV-2 genome distressed life in almost every discipline by the extended production of novel viral variants.
  • 1.1K
  • 17 May 2023
Topic Review
Vaccine Hesitancy
Vaccination, despite being recognized as one of the most effective primary public health measures, is viewed as unsafe and unnecessary by an increasing number of individuals. Vaccination is one of the most significant public health achievements, having contributed to the eradication of smallpox and the control of many infectious diseases such as rubella, diphtheria, and polio globally.
  • 1.1K
  • 20 Oct 2022
Topic Review
Multidrug Resistant Pseudomonas aeruginosa in Lebanon
Pseudomonas aeruginosa is a common cause of healthcare-associated infections and chronic airway diseases in non-clinical settings. P. aeruginosa is intrinsically resistant to a variety of antimicrobials and has the ability to acquire resistance to others, causing increasingly recalcitrant infections and elevating public health concerns. It is showed that the bacterium was predominant in lesions of patients on mechanical ventilation and in burn patients and those with diabetic foot infections and hematological malignancies. It is also found that carbapenem resistance in P. aeruginosa isolates in Lebanon involved both enzymatic and non-enzymatic mechanisms but depended predominantly on VIM-2 production (40.7%). Additionally, MDR P. aeruginosa was detected in animals, where a study reported the emergence of carbapenemase-producing P. aeruginosa in livestock in Lebanon.
  • 1.1K
  • 10 Jun 2022
Topic Review
SARS-CoV-2 Variants
The emergence of SARS-CoV-2 variants have significantly impact the course of COVID-19 pandemic worldwide. They have in common a higher transmissibility, becoming dominant within populations in a short time, and an accumulation of a high number of mutations in the spike (S) protein, especially within the amino terminal domain (NTD) and the receptor binding domain (RBD) which could affect the efficacy of the current licenced vaccines. 
  • 1.1K
  • 24 May 2021
Topic Review
Disulfiram
The literature has suggested that disulfiram (DSM) may be a potent drug in the armamentarium of physicians who treat chronic Lyme disease. The use of disulfiram in the treatment of Lyme disease started with a researcher who determined that DSM is bactericidal to spirochete. 
  • 1.1K
  • 08 May 2023
Topic Review
Tuberculosis Treatment and Impact of Drug Delivery Systems
With an incidence of ten million cases and between one and two million deaths each year, Mycobacterium tuberculosis is the deadliest infectious agent currently. In this entry, the general physiopathology of tuberculosis is described, as well as the drugs constituting the first- and second-line treatments. The potential of nanosized drug delivery systems for the treatment of tuberculosis is also highlighted.
  • 1.1K
  • 31 Mar 2023
Topic Review
Mucormycosis
Mucormycosis (also called zygomycosis) is a serious fungal infection caused by a group of molds called mucoromycetes. The types of fungi that mostly cause mucormycosis include Rhizopus spp., Mucor spp., Rhizomucor spp., Syncephalastrum spp., Cunninghamella bertholletia, Apophysomyces spp., and Lichtheimia (formerly Absidia) spp.
  • 1.1K
  • 09 Oct 2021
Topic Review
SARS-CoV-2 Intermittent Virulence
Pandemic viruses do not always show decreased virulence. Instead, it appears there is an evolutionary equilibrium between transmissibility and virulence. It can be termed this concept “intermittent virulence”. There is a high possibility that new virulent variants will arise in the near future, although it is improbable that SARS-CoV-2’s virulence will be the same as was seen during the alpha or delta waves, due to the fact that the human population has reached a sufficient level of herd immunity through natural infection or due to the vaccination programs. The most recent global mortality data raised the question of whether this pandemic is really over. Furthermore, it is uncertain when the endemic phase will begin. Darwin’s words: “the survival of the fittest” are still valid, and the virus will continue killing nonvaccinated old people, vaccinated old people, and those with comorbidities.
  • 1.1K
  • 08 Aug 2022
  • Page
  • of
  • 32
Academic Video Service